Maria Hopman is creating an e-health program for cardiac rehabilitation together with a consortium of Danish and Swiss companies. The consortium has been awarded a Eurostars grant of € 1.9 million for this program. Starting in 2021, the program will be available for physiotherapists and hospitals in Europe.Every year, more than 3 million people in Europe experience a heart attack. For half of them, this is not the first time. Most of these recurrent heart attacks can be prevented by improving the lifestyle after the first heart attack, for which patients are often offered cardiac rehabilitation. These programs consist of exercise and lifestyle recommendations. Cardiac rehabilitation is provided at specialized centers.
According to estimates, if all cardiac patients were to undergo cardiac rehabilitation, the mortality from myocardial infarctions could fall by 26 percent and hospital admissions by more than 30 percent. Despite these benefits, less than half of cardiac patients receive cardiac rehabilitation. This lack of participation is mainly due the distance to the cardiac rehabilitation centers, which patients experience as being too far. There are also many objections to the limited possibilities for taking an individualized program.
Research has shown that an internet-based rehabilitation program can achieve the same results as rehabilitation at a center. An e-health application for cardiac rehabilitation could therefore eliminate many obstacles for patients. However, such an application is not yet available. With Eurostar funding of € 1.9 million, a European consortium of researchers and companies will create CaRe, a mobile platform for cardiac rehabilitation.
CaRe is a consortium consisting of the Danish companies Welfare Denmark and Tutee, the Swiss company Ateleris and the research group of Maria Hopman at Radboud university medical center. With the CaRe program, patients can rehabilitate at home. They can set their own goals, maintain contact with their therapist via the internet and follow an individualized training program. The initiators of CaRe hope that this will increase the number of participants in cardiac rehabilitation.
CaRe is expected to be available worldwide in 2021 to physiotherapists and hospitals offering cardiac rehabilitation.
Eurostars is an EU program of the Eureka network for financing projects led by small or medium-sized companies that spend at least 10% of their turnover or working hours on research activities.
Maria Hopman is member of theme Mitochondrial diseases.
Related news items
A personal touch of Elianne Bulthuis6 December 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Elianne Bulthuisread more
Discover Israels' secret to startup success6 December 2018
International exchange of staff is an indispensable part of one’s personal and professional growth. In the context of entrepreneurship, exciting career opportunities and networking an educational and inspiring trip to Israel is planned. You are invited to join for free (only for PhD's).read more
René Vogels Stichting travel grant for Pieter Roelofs4 December 2018
Pieter Roelofs received the award in order to perform a work visit to prof. Reuben Harris’ lab at the University of Minnesota, USA.read more
Symposium on inclusive research Monday 14 January 20194 December 2018
How does inclusive research with people with intellectual disabilities work? The academic collaborative ‘Sterker op eigen benen’ invites you to this free symposium ‘Inclusief onderzoek in ‘t eggie’ followed by the PhD defense of Tessa Frankena.read more
MRI improves detection of prostate cancer Prostate biopsy no longer necessary for 50% of male patients4 December 2018
There is good news for the more than 40,000 men per year who go to the hospital for diagnosis because of elevated Prostate-Specific Antigen (PSA) levels. “Thanks to the use of MRI, we can reduce the number of prostate biopsies by half,” says Jelle Barentsz.read more